uk 68798 has been researched along with Ventricular Fibrillation in 24 studies
*Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (50.00) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 5 (20.83) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagli, JF; Ellingboe, JW; Kitzen, JM; Moubarak, IF; Nguyen, TT; Parsons, RW; Spinelli, W; Von Engen, D; Winkley, MW | 1 |
| Osadchii, OE | 1 |
| Agusala, K; Caprio, T; Kulkarni, C; Oesterle, A; Passman, R; Subacius, H | 1 |
| Bapat, A; Cao, H; Eskandari, A; Karagueuzian, HS; Ko, CY; Nguyen, T; Nivala, M; Pezhouman, A; Qu, Z; Singh, N; Song, Z; Weiss, JN | 1 |
| Bhavnani, SP; Clyne, CA; Coleman, CI; Guertin, D; Kluger, J; Shafi, NA; White, CM; Yarlagadda, RK | 1 |
| Banchs, JE; Baquero, GA; Depalma, S; Gonzalez, MD; Naccarelli, GV; Penny-Peterson, ED; Samii, SM; Wolbrette, DL; Young, SK | 1 |
| Singh, BN | 1 |
| Amitzur, G; Eldar, M; Leor, J; Novikov, I; Shenkar, N | 1 |
| Kolb, C; Ndrepepa, G; Zrenner, B | 1 |
| De Clerck, F; Lu, HR; Remeysen, P | 1 |
| Chi, L; Friedrichs, GS; Green, AL; Lucchesi, BR | 1 |
| Andersen, HR; Christiansen, N; Knudsen, LL; Simonsen, I; Thomsen, PE; Wiggers, H | 1 |
| Bril, A; Feuerstein, GZ; Gout, B; Nichols, AJ | 1 |
| Chen, J; Eto, K; Hashimoto, K; Ni, C; Xue, Y | 1 |
| Carnes, CA; Mehdirad, AA; Nelson, SD | 1 |
| Gillis, AM; Kulisz, E; Lester, WM; Mathison, HJ | 1 |
| DiMarco, JP; Mounsey, JP | 1 |
| Bányász, T; Gyönös, I; Kovács, A; Magyar, J; Nánási, PP; Spedding, M; Szénási, G | 1 |
| Dorian, P; Qi, X | 1 |
| Bacchi, L; Biffi, M; Boriani, G; Branzi, A; Butrous, GS; Martignani, C; Zannoli, R | 1 |
| Colatsky, TJ; Parsons, RW; Spinelli, W | 1 |
| Blackburn, KJ; Burges, RA; Gwilt, M; Higgins, AJ; Milne, AA; Solca, AM | 1 |
| Black, SC; Chi, LG; Lucchesi, BR; Mu, DX | 1 |
| Corr, PB; Zuanetti, G | 1 |
3 review(s) available for uk 68798 and Ventricular Fibrillation
| Article | Year |
|---|---|
Significance and control of cardiac arrhythmias in patients with congestive cardiac failure.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Death, Sudden, Cardiac; Defibrillators, Implantable; Drug Therapy, Combination; Heart Failure; Humans; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Ventricular Fibrillation | 2002 |
Cardiovascular drugs. Dofetilide.
Topics: Action Potentials; Administration, Oral; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Controlled Clinical Trials as Topic; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Humans; Phenethylamines; Potassium; Potassium Channel Blockers; Potassium Channels; Reaction Time; Sulfonamides; Treatment Outcome; Ventricular Fibrillation | 2000 |
Antiarrhythmic drugs and ventricular defibrillation energy requirements.
Topics: Animals; Anti-Arrhythmia Agents; Defibrillators, Implantable; Humans; Phenethylamines; Sotalol; Sulfonamides; Ventricular Fibrillation | 1999 |
2 trial(s) available for uk 68798 and Ventricular Fibrillation
| Article | Year |
|---|---|
Dofetilide reduces the incidence of ventricular fibrillation during acute myocardial ischaemia. A randomised study in pigs.
Topics: Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disease Models, Animal; Electrocardiography; Myocardial Ischemia; Phenethylamines; Potassium Channels; Sulfonamides; Swine; Ventricular Fibrillation | 1994 |
A randomised cross-over study on the haemodynamic effects of oral dofetilide compared with oral sotalol in patients with ischaemic heart disease and sustained ventricular tachycardia.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Cross-Over Studies; Hemodynamics; Humans; Middle Aged; Myocardial Ischemia; Phenethylamines; Sotalol; Sulfonamides; Ventricular Fibrillation | 2002 |
19 other study(ies) available for uk 68798 and Ventricular Fibrillation
| Article | Year |
|---|---|
Class III antiarrhythmic activity of novel substituted 4-[(methylsulfonyl)amino]benzamides and sulfonamides.
Topics: Action Potentials; Anti-Arrhythmia Agents; Atrial Function; Benzamides; Benzimidazoles; Biological Availability; Electric Conductivity; Heart Atria; Heart Conduction System; Heart Ventricles; Membrane Potentials; Molecular Structure; Myocardial Contraction; Purkinje Fibers; Structure-Activity Relationship; Sulfanilamides; Sulfonamides; Ventricular Fibrillation; Ventricular Function | 1992 |
Effects of antiarrhythmics on the electrical restitution in perfused guinea-pig heart are critically determined by the applied cardiac pacing protocol.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electrocardiography; Female; Guinea Pigs; Heart; Heart Conduction System; Heart Ventricles; Phenethylamines; Quinidine; Refractory Period, Electrophysiological; Sulfonamides; Ventricular Fibrillation | 2019 |
Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Illinois; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Prevalence; Retrospective Studies; Risk Factors; Sotalol; Sulfonamides; Treatment Outcome; Ventricular Fibrillation | 2015 |
Molecular Basis of Hypokalemia-Induced Ventricular Fibrillation.
Topics: Action Potentials; Animals; Benzylamines; Computer Simulation; Hypokalemia; Male; Phenethylamines; Pyridines; Rabbits; Rats; Rats, Inbred F344; Sodium-Potassium-Exchanging ATPase; Sulfonamides; Triazoles; Ventricular Fibrillation | 2015 |
The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators.
Topics: Aged; Anti-Arrhythmia Agents; Cohort Studies; Confidence Intervals; Connecticut; Defibrillators, Implantable; Digoxin; Electrophysiology; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Phenethylamines; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2010 |
Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Topics: Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Coronary Artery Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Dose-Response Relationship, Drug; Electric Countershock; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Phenethylamines; Recurrence; Stroke Volume; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation; Ventricular Function, Left | 2012 |
Modulation of ventricular fibrillation in isolated perfused heart by dofetilide.
Topics: Animals; Anti-Arrhythmia Agents; Cation Transport Proteins; Cats; Electrophysiologic Techniques, Cardiac; Ether-A-Go-Go Potassium Channels; Female; Heart Rate; Heart Ventricles; In Vitro Techniques; Male; Models, Biological; Myocardial Reperfusion; Phenethylamines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Sulfonamides; Time Factors; Ventricular Fibrillation | 2003 |
Late dofetilide-associated life-threatening proarrhythmia.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Defibrillators, Implantable; Electrocardiography; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Ventricular Fibrillation | 2008 |
Antifibrillary action of class I-IV antiarrhythmic agents in the model of ventricular fibrillation threshold of anesthetized guinea pigs.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atenolol; Benzopyrans; Chromans; Disease Models, Animal; Electric Stimulation; Electrocardiography; Encainide; Ethanolamines; Guinea Pigs; Heart; Heart Conduction System; Injections, Intravenous; Male; Metoprolol; Nebivolol; Phenethylamines; Piperidines; Sotalol; Sulfonamides; Ventricular Fibrillation; Verapamil | 1995 |
Antifibrillatory effects of clofilium in the rabbit isolated heart.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Decanoic Acids; Disease Models, Animal; Glyburide; Heart; Hydroxy Acids; In Vitro Techniques; Myocardium; Oxygen Consumption; Patch-Clamp Techniques; Phenethylamines; Potassium Channels; Quaternary Ammonium Compounds; Rabbits; Refractory Period, Electrophysiological; Sulfonamides; Ventricular Fibrillation; Ventricular Pressure | 1994 |
Antifibrillatory effects of BRL-32872 in anesthetized Yucatan minipigs with regional myocardial ischemia.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Benzamides; Disease Models, Animal; Flecainide; Injections, Intravenous; Myocardial Ischemia; Myocardial Reperfusion Injury; Phenethylamines; Sulfonamides; Swine; Swine, Miniature; Ventricular Fibrillation | 1995 |
Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Digitalis; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Epinephrine; Female; Male; Myocardial Infarction; Myocardial Reperfusion; Phenethylamines; Plants, Medicinal; Plants, Toxic; Sulfonamides; Tachycardia, Ventricular; Ventricular Fibrillation | 1996 |
The influence of specific and nonspecific potassium current blockade on the defibrillation energy requirement of biphasic shock.
Topics: Action Potentials; Aminobenzoates; Animals; Anti-Arrhythmia Agents; Bridged Bicyclo Compounds, Heterocyclic; Defibrillators, Implantable; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electric Countershock; Electrocardiography; Female; Heart Rate; Infusions, Intravenous; Male; Phenethylamines; Pilot Projects; Potassium Channel Blockers; Potassium Channels; Sulfonamides; Treatment Outcome; Ventricular Fibrillation | 1999 |
Dispersion of ventricular repolarization and ventricular fibrillation in left ventricular hypertrophy: influence of selective potassium channel blockers.
Topics: 4-Aminopyridine; Action Potentials; Animals; Anti-Arrhythmia Agents; Hypertrophy, Right Ventricular; In Vitro Techniques; Male; Perfusion; Phenethylamines; Potassium Channel Blockers; Rabbits; Sulfonamides; Time Factors; Ventricular Fibrillation; Ventricular Pressure | 2000 |
Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation in vivo and in vitro.
Topics: Animals; Anti-Arrhythmia Agents; Cats; Dose-Response Relationship, Drug; Electric Stimulation; Female; Hemodynamics; Male; Papillary Muscles; Phenethylamines; Pyridazines; Rabbits; Sotalol; Sulfonamides; Ventricular Fibrillation; Ventricular Function, Right | 2001 |
Effects of WAY-123,398, a new class III antiarrhythmic agent, on cardiac refractoriness and ventricular fibrillation threshold in anesthetized dogs: a comparison with UK-68798, E-4031, and dl-sotalol.
Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Atrioventricular Node; Benzimidazoles; Dogs; Electrocardiography; Electrophysiology; Female; Heart; Heart Conduction System; Hemodynamics; In Vitro Techniques; Male; Phenethylamines; Piperidines; Purkinje Fibers; Pyridines; Refractory Period, Electrophysiological; Sotalol; Sulfanilamides; Sulfonamides; Ventricular Fibrillation | 1992 |
Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogs.
Topics: Action Potentials; Anesthesia; Animals; Anti-Arrhythmia Agents; Dogs; Heart; Heart Ventricles; Hemodynamics; Phenethylamines; Potassium Channels; Procainamide; Refractory Period, Electrophysiological; Sotalol; Sulfonamides; Ventricular Fibrillation | 1992 |
The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Death, Sudden; Dogs; Electric Stimulation; Electrocardiography; Male; Phenethylamines; Potassium Channels; Refractory Period, Electrophysiological; Sulfonamides; Ventricular Fibrillation | 1991 |
Antiarrhythmic efficacy of a new class III agent, UK-68,798, during chronic myocardial infarction: evaluation using three-dimensional mapping.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Dogs; Electric Stimulation; Electrocardiography; Heart; Heart Conduction System; Heart Ventricles; Myocardial Infarction; Phenethylamines; Sulfonamides; Tachycardia; Ventricular Fibrillation | 1991 |